This inventor holds 2 USPTO granted patents. Top assignees: Avigen, Inc., Other. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2001-2004
Title: Edgar G Engelman: Innovator in Immunization Technologies
Introduction
Edgar G Engelman is a notable inventor based in Atherton, CA (US). He has made significant contributions to the field of immunization through his innovative approaches and patented technologies. With a total of 2 patents, Engelman has focused on advancing methods for inducing immune responses using recombinant viral vectors.
Latest Patents
Engelman's latest patents include groundbreaking work on the induction of immune response to antigens expressed by recombinant adeno-associated virus. The present invention relates generally to immunization methods using recombinant viral vectors. In particular, the invention details methods and compositions for immunizing a subject with a nucleic acid molecule encoding an antigen of interest. This nucleic acid molecule is delivered to the subject via a recombinant AAV virion, showcasing Engelman's commitment to enhancing immunization techniques.
Career Highlights
Throughout his career, Engelman has worked with various organizations, including Avigen, Inc. His work has been instrumental in developing innovative solutions in the field of immunology. Engelman's contributions have not only advanced scientific understanding but have also paved the way for new therapeutic approaches.
Collaborations
Engelman has collaborated with notable professionals in his field, including Dirk G Brockstedt and Greg M Podsakoff. These collaborations have further enriched his research and development efforts, leading to impactful innovations.
Conclusion
Edgar G Engelman stands out as a prominent inventor in the realm of immunization technologies. His patents and collaborative efforts reflect his dedication to advancing medical science and improving health outcomes. Engelman's work continues to influence the field of immunology and inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile